Corona Remedies Ltd
Company Profile
Business description
Corona Remedies Ltd is a pharmaceutical formulation company engaged in developing, manufacturing and marketing products in women’s healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. The company offers products across the following therapeutic areas: (i) women’s health; (ii) cardio-diabeto, (iii) pain management; (iv) urology; and (v) others/multispecialty pharmaceuticals (comprising VMN, gastrointestinal and respiratory). The company operates in only one reportable business segment i.e. ‘pharmaceuticals’. It generates a substantial portion of its revenue from operations from certain therapeutic areas in India, with the majority coming from women’s healthcare.
Contact
S. G. Highway, CORONA House
C - Mondeal Business Park, Near Gurudwara
Thaltej
AhmedabadGJ380 059
INDT: +91 7940233000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2026
Employees
4,573
Stocks News & Analysis
stocks
Investors overly negative on cheap ASX share
stocks
Overvalued US AI play reports earnings
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,918.30 | 4.70 | 0.05% |
| CAC 40 | 8,151.38 | 0.74 | 0.01% |
| DAX 40 | 24,288.40 | 88.90 | 0.37% |
| Dow JONES (US) | 48,134.89 | 183.04 | 0.38% |
| FTSE 100 | 9,897.42 | 59.65 | 0.61% |
| HKSE | 25,690.53 | 192.40 | 0.75% |
| NASDAQ | 23,307.62 | 301.26 | 1.31% |
| Nikkei 225 | 49,507.21 | 505.71 | 1.03% |
| NZX 50 Index | 13,333.40 | 76.63 | 0.58% |
| S&P 500 | 6,834.50 | 59.74 | 0.88% |
| S&P/ASX 200 | 8,621.40 | 0.10 | -0.00% |
| SSE Composite Index | 3,890.45 | 14.08 | 0.36% |